Sally E. Blount - 28 Apr 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Sally E. Blount by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
28 Apr 2023
Transactions value $
$0
Form type
4
Filing time
02 May 2023, 19:42:08 UTC
Previous filing
03 May 2022
Next filing
30 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Award $0 +1.82K +5.79% $0.00 33.2K 28 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).